Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PLAGL1 Monoclonal Antibody (8D8C5)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA531853
Description
MA5-31853 has been tested in indirect ELISA.
This gene encodes a C2H2 zinc finger protein with transactivation and DNA-binding activities. It has been shown to have anti-proliferative properties, and thus thought to function as a tumor suppressor. In addition, overexpression of this gene during fetal development is believed to underlie the rare disorder, transient neonatal diabetes mellitus (TNDM). This gene is imprinted, with preferential expression of the paternal allele in many tissues, however, biallelic expression has been noted in peripheral blood leucocytes. A recent study reports that tissue-specific imprinting results from variable utilization of monoallelic and biallelic promoters. Many transcript variants differing in the 5' UTR and encoding two different isoforms, have been found for this gene.
Specifications
PLAGL1 | |
Monoclonal | |
1 mg/mL | |
PBS with 0.05% sodium azide | |
Q9UM63 | |
Plagl1 | |
Purified recombinant fragment of human PLAGL1 (AA: 118-222) expressed in E. coli. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG1 |
ELISA, Immunohistochemistry (Paraffin), Western Blot | |
8D8C5 | |
Unconjugated | |
Plagl1 | |
Lost on transformation 1; LOT1; LOT-1; PLAG1 like zinc finger 1; PLAGL1; PLAG-like 1; pleiomorphic adenoma gene-like 1; Pleiomorphic adenoma-like protein 1; Tumor suppressor ZAC; ZAC; Zac1; zinc finger protein PLAGL1; zinc finger protein regulator of apoptosis and cell cycle arrest; zinc finger protein Zac 1 | |
Mouse | |
Protein G | |
RUO | |
5325 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction